Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

MiniMed 780G to add automated correction boluses and Bluetooth, aims to launch by April 2020; Guardian Connect users can now use IQcast on Apple iPhones
FreeStyle Libre 14-Day Now Available, G6 ships to Medicare users in early 2019
The ambitious national research program launched in 2018; how far has it come, and what will come out of it?
Dr. Diana Isaacs on CGM, “shared” appointments, and identifying “Bright Spots” and “Landmines.” Plus, how to find a Diabetes Care and Education Specialist near you
The EMA approved Zynquista (sotagliflozin), an SGLT-1/2 dual inhibitor, for adults with a BMI above 27
SGLT-1/2 therapy for type 1 diabetes, hybrid closed loop systems in teens and children, and the importance of glucose control as an outcome in addition to A1C!
Called “Insulin Lispro,” the generic version of Humalog may benefit those paying cash or with high-deductible health plans
A recent study found 38% of those with type 1 diagnosed after age 30 were not initially given insulin; learn ways of differentiating between type 1 and type 2 at...
Insightful diabetes leaders discuss high-potential areas ranging from SGLT-2s in type 1 diabetes, personalized treatment plans, and the do-it-yourself Loop app
JDRF Chief Mission Officer Dr. Aaron Kowalski has been named the organization’s next President and CEO. See our exclusive interview with Dr. Kowalski!
If approved, Lilly’s intranasal glucagon would be a radical ease-of-use improvement over current glucagon kits for severe hypoglycemia
CGM data in people without diabetes, time-in-range and A1C benefits in large hybrid closed loop study, plus trial results studying Jardiance in type 1 as well as Lilly’s...
A study finds that packaged snacks, pre-prepared meals, and other “ultra-processed” foods lead to weight gain; unprocessed foods lead to weight loss
Surprising study findings from a look at refrigerator temperatures and the risk posed to insulin quality; plus, a guide to safe insulin storage and Med Angel’s very cool...
Low-carb pizza, low-cost produce home delivered, staying in-range during long exercise (UCAN), getting paid for steps, and Starbucks’ egg bites
Read about a new cauliflower pizza crust, alongside updates on Senseonics Eversense CGM, Medtronic’s new CGM points program, the Beyond A1C movement, Tandem’s Basal-IQ,...
FlowSmart infusion set officially discontinued. On the plus side, BD plans to launch a tubeless type 2 diabetes insulin patch pump starting in late 2019.
Amarin’s Vascepa, an omega-3 fatty acid, is shown to lower risk of heart attack, stroke, and heart-related death for adults with high risk for heart disease with...
A preview of the most exciting conference updates on diabetes drugs, devices, and more; stay tuned!
The first trial, now recruiting 50 people, is an observational study of insulin requirements and glucose levels using the Dexcom G6 CGM in type 1 pregnancy.

Pages